Recombinant Anti-Siglec-2/CD22 Antibody (PE), Rabbit Monoclonal sinobiological 51177-R026-P

$100.00
In stock
SKU
51177-R026-P
Catalog No.SizePrice (USD)
51177-R026-P-2525 Tests$103.68
51177-R026-P-100100 Tests$325.84

General Information

Product nameRecombinant Anti-Siglec-2/CD22 Antibody (PE), Rabbit Monoclonal
Validated applicationsFCM (FAQ Protocol)
Species reactivityReacts with: Mouse
SpecificityMouse Siglec-2/CD22
ImmunogenRecombinant Mouse CD22 Protein (Catalog#51177-M08H)
PreparationThis antibody was obtained from a rabbit immunized with purified, recombinant Mouse CD22 (rM CD22; Catalog#51177-M08H; BAE33829.1; Met1-Arg708) and conjugated with PE under optimum conditions, the unreacted PE was removed.
SourceMonoclonal Rabbit IgG Clone #026
PurificationProtein A
FormulationPBS solution containing 0.5% BSA and 0.09% sodium azide
Concentration5 μl/Test, 0.1 mg/ml
ConjugatePE
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

Synonyms: Anti-A530093D23 Antibody; Anti-Cd22 Antibody; Anti-Lyb-8 Antibody; Anti-Lyb8 Antibody; Anti-Siglec2 Antibody

Image / Experimental Information

Image 1 DescriptionFlow cytometric analysis of Mouse CD22 expression on BABL/c splenocytes. Cells were stained with PE-conjugated anti-Mouse CD22. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.
Image 1 Alt TextMouse CD22/Siglec-2 Flow Cytometry (FC) 4971
Image 1 URLSource image

Background Information

Full NameCD22 molecule
DescriptionCD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.
Research Areas
  • Cancer Drug Targets
  • ITIM/ITAM Immunoreceptors and Related Molecules
Related Pathways
  • B Cell Receptor Signaling Pathway
Tags
  • Cancer Immunotherapy
  • Immune Checkpoint
  • Immunotherapy
  • Targeted Therapy
References
  1. Tedder TF, et al. (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol. 15: 481-504.
  2. Tedder TF, et al. (2005) CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 88: 1-50.
  3. Fujimoto M, et al. (2007) B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci. 46(1): 1-9.
  4. Walker JA, et al. (2008) CD22: an inhibitory enigma. Immunology. 123(3): 314-25.
  5. Nitschke L. (2009) CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev. 230(1): 128-43.

Reviews

Write Your Own Review
You're reviewing:Recombinant Anti-Siglec-2/CD22 Antibody (PE), Rabbit Monoclonal sinobiological 51177-R026-P
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.